For the first time in decades, the U.S. federal government is seriously reconsidering how it classifies cannabis under the Controlled Substances Act. The review follows widespread state-level legalization and public support for reform, signaling a potential turning point in national drug policy.
Currently, cannabis is listed as a Schedule I substance, a category reserved for drugs viewed as having no accepted medical use and a high potential for misuse. This classification, established in 1970, has remained unchanged despite growing evidence of medical benefits and an expanding legal market across many states.
In 2023, the U.S. Department of Health and Human Services (HHS) recommended that cannabis be reclassified to Schedule III, a category that includes substances with accepted medical uses and lower misuse potential. The Drug Enforcement Administration (DEA) is now reviewing that recommendation before issuing a final decision.
Reclassification would not federally legalize cannabis but would represent a major policy shift. It could ease research restrictions, alter federal taxation rules for cannabis businesses, and bring federal standards closer to those of state-regulated markets. However, barriers such as interstate commerce limits and banking restrictions would remain until Congress enacts broader legislation.
The federal review reflects a broader change in public perception. Surveys show that a majority of Americans support medical cannabis access, and many favor further decriminalization or legalization. Policymakers and researchers view this as a sign that national attitudes toward cannabis have evolved significantly since the 1970s.
While the DEA’s review is ongoing, the outcome could have lasting effects on healthcare, scientific study, and the legal cannabis industry. Whatever the result, this marks the most significant federal reconsideration of cannabis
FBI agents raided former Trump national security adviser John Bolton’s Maryland home Friday morning in a revived classified documents probe tied to his 2020 memoir and handling of sensitive material. The investigation was first opened under Trump but later shelved during Biden’s term. FBI Director Kash Patel ordered the raid, calling it part of his…
When Claire receives a cold, final letter from her beloved grandmother—the woman who raised her—she’s stunned. “Don’t visit me anymore. I’ve changed the locks. I need peace. Don’t call. Don’t write.” The words don’t make sense. Nothing had been wrong on their last visit—cookies, hugs, laughter.She calls her sisters. Both received the same letter. Marie is confused….
Washington, D.C. — President Donald Trump reignited his feud with Senator Adam Schiff (D-Calif.) this week, accusing the longtime political rival of committing mortgage fraud tied to a Maryland home he purchased while serving in Congress. Schiff has dismissed the claims as unfounded. Trump’s Accusation In a post on his Truth Social platform, Trump labeled Schiff a “scam artist” and…
During the 78th Locarno Film Festival, Oscar-winning actress Emma Thompson recounted an unexpected incident from the late 1990s involving former U.S. President Donald Trump. At that time, Thompson had just completed her divorce from actor Kenneth Branagh and was on the set of the film Primary Colors when she received an unexpected phone call. The…
Karen Attiah, a longtime opinion columnist at The Washington Post, has been dismissed after posting a series of controversial remarks on social media in the wake of conservative commentator Charlie Kirk’s assassination. The decision, announced internally last week and later confirmed by Attiah herself, has reignited debate over the intersection of journalism, free expression, and…
Twelve years ago, in the central Russian city of Cheboksary, two young people, ages twenty-five and twenty-two, respectively, named Ilya Zhirnov and Kira Cherkasova, vanished from sight. Until the amateur diver discovered their automobile at the bottom of the river, no one knew what had happened to them. The police claimed that the car had…